when should you not take semaglutide Maximizing Semaglutide: Understanding the Doses for Diabetes & Weight Loss Why Am I Not Losing

Combination of exercise and GLP1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial

Explore semaglutide telehealth options to begin your journey from the comfort of your home

Scale Our robust architectural and operational capacity allows us to support large-scale obesity and diabetes clinical trials across the globe, currently hosting over 600 active ePRO trials

Revolutionary treatments with real results How do GLP-1 injections work

Renal effects and safety between Asian and non-Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists

Particular attention is needed for potential effects on pancreatic safety, including pancreatitis and pancreatic cancer risk